Pharmasset (VRUS) Reports Inline Q4 Loss of $0.53
More News related to VRUS
- After-Hours Movers 2/9: MCZ, NTGR, CYBI, BIDU, RMTR, FNSR Higher; QUIK, LGF, APPY, VRUS, EXBD Lower
- Pharmasset, Inc. (VRUS) Posts Q4 Loss of $0.49, Wider than Expectations
- Pharmasset Reports Fiscal First Quarter 2010 Financial Results
- Pharmasset (VRUS) Files $150M Mixed Shelf
- Pharmasset Announces Exercise of Underwriter's Option
More News related to Earnings
- ArcelorMittal (MT) Posts Strong Q4 EPS of $0.68, Tops Views
- Sprint Nextel (S) Posts Q4 adj.-EPS of $0.34, Wider than Views
- EOG Resources (EOG) Posts Q4 EPS of $0.92, Misses Views; Increases Dividend to $0.155, Yields 0.7%
- Douglas Emmett (DEI) Posts Q4 FFO of $0.30, In-Line with Street Estimates
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
Pharmasset, Inc. (Nasdaq: VRUS) reports Q4 loss of $0.53, inline with the analyst estimate of ($0.53).
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
